Symptom burden in glioblastoma - a prospective pilot study from diagnosis to first progression

CONCLUSION: The proposed clinical toolkit seems feasible in routine clinical practice and reflects changes in symptom burden in different stages of the post-surgical course of GBM patients in this monocentric clinical pilot trial.PMID:35780772 | DOI:10.1159/000525651

Source: Oncology - July 5, 2022 Category: Cancer & Oncology Authors: Ulrich Roelcke Lucia Schwyzer Anna Maria Zeitlberger Thomas Hundsberger Source Type: research